Mumbai, India

Rajkumar Dhar

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajkumar Dhar. Retrieved from https://idiyas.com/inventor/rajkumar-dhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajkumar Dhar: Innovator in Pharmaceutical Chemistry

Introduction

Rajkumar Dhar is a notable inventor based in Bombay, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on creating innovative solutions to combat various diseases.

Latest Patents

Rajkumar Dhar holds a patent for "1-substituted 3-aryl-7-chloro-3,4-dihydro(2H)-acridone N-oxides." This invention relates to novel compounds that have potential use as chemotherapeutic agents, specifically as antimalarials and coccidiostatics. The patent outlines a process for the preparation of these compounds, as well as pharmaceutical compositions containing them.

Career Highlights

Rajkumar Dhar is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at the company has allowed him to focus on research and development, contributing to advancements in drug formulation and therapeutic efficacy.

Collaborations

Throughout his career, Rajkumar has collaborated with esteemed colleagues, including Bindumadhavan Venugopalan and Dipak K Chatterjee. These collaborations have fostered a productive environment for innovation and research in pharmaceutical sciences.

Conclusion

Rajkumar Dhar's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing health challenges. His patent for novel compounds highlights the importance of research in developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…